Study Finds What Causes Metabolic Disease

by Kathy Jones on  July 17, 2010 at 10:24 PM Research News
RSS Email Print This Page Comment
The gene mutation responsible for a condition in which eye and brain development is severely disrupted in infants has been discovered by researchers.

They also suggest a potential remedy that would involve a simple, daily dietary supplement.
 Study Finds What Causes Metabolic Disease
Study Finds What Causes Metabolic Disease
Advertisement

The condition is one of the congenital disorders of glycosylation or CDG, a group of syndromes in which inborn metabolic errors result in serious, sometimes fatal, malfunctions of different organ systems, especially the nervous system, muscles and intestines.

Advertisement
The researchers have discovered that the gene SRD5A3 is responsible for the synthesis of a lipid used by cells as a sugar carrier for protein glycosylation in which proteins are modified by the addition of a sugar or sugar chain.

"We found the long-sought polyprenol reductase that has been suspected for decades" said Joseph G. Gleeson of Howard Hughes Medical Institute.

"Using a human genetic approach, we were able to not only find a clue to understand this class of disorder, but also to solve a basic science problem," he added.

"Dolichol is used by the cell like a truck to transport glycans to their destination but also as a support to build them" said Vincent Cantagrel of UC San Diego.

"A defect in this transportation results in a less efficient process of glycosylation. Some proteins will miss some glycan chains and will not function correctly," he added.

In CDG cases, the conversion from polyprenol to dolichol is blocked by a mutation in the SRD5A3 gene.

"The mutation is inherited recessively. Both parents must pass along a mutated copy, which is why you don't see it so much in the US. However, in the Middle East, where marriage of cousins is common, these diseases are much more prevalent," said Gleeson.

Identifying the blockage, Gleeson said, pointed to a possible treatment.

"The key was identifying the enzyme's role in producing dolichol. This is the basic step that is blocked in our patients, and the disease is the result.

"Our idea is that if you feed these patients dolichol, that might just treat the condition. It would be similar to giving insulin to diabetics. It's a simple solution, but one nobody had thought of," he added.

The findings were published in an online journal Cell.

Source: ANI
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Syndrome X 
Advertisement

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive